AAAAAA

   
Results: 1-21 |
Results: 21
MODULATION OF O-6-ALKYLATING AGENT INDUCED CLASTOGENICITY BY ENHANCEDDNA-REPAIR CAPACITY OF BONE-MARROW CELLS
Authors: CHINNASAMY N FAIRBAIRN LJ LAHER J WILLINGTON MA RAFFERTY JA
Citation: N. Chinnasamy et al., MODULATION OF O-6-ALKYLATING AGENT INDUCED CLASTOGENICITY BY ENHANCEDDNA-REPAIR CAPACITY OF BONE-MARROW CELLS, Mutation research. Genetic toxicology and environmental mutagenesis, 416(1-2), 1998, pp. 1-10
CD34(-TERM CULTURE-INITIATING CELLS, NOD()AC133(+) CELLS ISOLATED FROM CORD BLOOD ARE HIGHLY ENRICHED IN LONG)SCID-REPOPULATING CELLS AND DENDRITIC CELL PROGENITORS/
Authors: DEWYNTER EA BUCK D HART C HEYWOOD R COUTINHO LH CLAYTON A RAFFERTY JA BURT D GUENECHEA G BUEREN JA GAGEN D FAIRBAIRN LJ LORD BI TESTA NG
Citation: Ea. Dewynter et al., CD34(-TERM CULTURE-INITIATING CELLS, NOD()AC133(+) CELLS ISOLATED FROM CORD BLOOD ARE HIGHLY ENRICHED IN LONG)SCID-REPOPULATING CELLS AND DENDRITIC CELL PROGENITORS/, Stem cells, 16(6), 1998, pp. 387-396
CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO
Authors: HICKSON I FAIRBAIRN LJ CHINNASAMY N LASHFORD LS THATCHER N MARGISON GP DEXTER TM RAFFERTY JA
Citation: I. Hickson et al., CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO, Gene therapy, 5(6), 1998, pp. 835-841
CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
Authors: CHINNASAMY N RAFFERTY JA HICKSON I LASHFORD LS LONGHURST SJ THATCHER N MARGISON GP DEXTER TM FAIRBAIRN LJ
Citation: N. Chinnasamy et al., CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, Gene therapy, 5(6), 1998, pp. 842-847
UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO
Authors: STEWART K BROWN OA MORELLI AE FAIRBAIRN LJ LASHFORD LS COOPER A HATTON CE DEXTER TM CASTRO MG LOWENSTEIN PR
Citation: K. Stewart et al., UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO, Gene therapy, 4(1), 1997, pp. 63-75
GENE-THERAPY FOR CHEMOPROTECTION OF BONE-MARROW FROM THE TOXIC AND CARCINOGENIC EFFECTS OF THE O-6-ALKYLATING AGENTS
Authors: RAFFERTY JA CHINNASAMY N HICKSON I MARGISON GP DEXTER TM FAIRBAIRN LJ
Citation: Ja. Rafferty et al., GENE-THERAPY FOR CHEMOPROTECTION OF BONE-MARROW FROM THE TOXIC AND CARCINOGENIC EFFECTS OF THE O-6-ALKYLATING AGENTS, Cancer gene therapy, 4(6), 1997, pp. 89-89
GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
Authors: CHINNASAMY N HICKSON I DEXTER TM MARGISON GP FAIRBAIRN LJ RAFFERTY JA
Citation: N. Chinnasamy et al., GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, Cancer gene therapy, 4(5), 1997, pp. 303-303
TOWARDS GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
Authors: HICKSON I FAIRBAIRN LJ CHINNASAMY N DEXTER TM MARGISON GP RAFFERTY JA
Citation: I. Hickson et al., TOWARDS GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, Cancer gene therapy, 4(1), 1997, pp. 70-70
O-6-BENZYLGUANINE POTENTIATES THE IN-VIVO TOXICITY AND CLASTOGENICITYOF TEMOZOLOMIDE AND BCNU IN MOUSE BONE-MARROW
Authors: CHINNASAMY N RAFFERTY JA HICKSON I ASHBY J TINWELL H MARGISON GP DEXTER TM FAIRBAIRN LJ
Citation: N. Chinnasamy et al., O-6-BENZYLGUANINE POTENTIATES THE IN-VIVO TOXICITY AND CLASTOGENICITYOF TEMOZOLOMIDE AND BCNU IN MOUSE BONE-MARROW, Blood, 89(5), 1997, pp. 1566-1573
PROTECTION OF MAMMALIAN-CELLS AGAINST CHLOROETHYLATING AGENT TOXICITYBY AN O-6-BENZYLGUANINE-RESISTANT MUTANT OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
Authors: HICKSON I FAIRBAIRN LJ CHINNASAMY N DEXTER TM MARGISON GP RAFFERTY JA
Citation: I. Hickson et al., PROTECTION OF MAMMALIAN-CELLS AGAINST CHLOROETHYLATING AGENT TOXICITYBY AN O-6-BENZYLGUANINE-RESISTANT MUTANT OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE, Gene therapy, 3(10), 1996, pp. 868-877
GENE-TRANSFER TO AUGMENT THE THERAPEUTIC INDEX OF ANTICANCER CHEMOTHERAPY
Authors: BAUM C MARGISON G ECKERT HG FAIRBAIRN LJ OSTERTAG W RAFFERTY JA
Citation: C. Baum et al., GENE-TRANSFER TO AUGMENT THE THERAPEUTIC INDEX OF ANTICANCER CHEMOTHERAPY, Gene therapy, 3(1), 1996, pp. 1-3
CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES
Authors: RAFFERTY JA HICKSON I CHINNASAMY N LASHFORD LS MARGISON GP DEXTER TM FAIRBAIRN LJ
Citation: Ja. Rafferty et al., CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES, Cancer metastasis reviews, 15(3), 1996, pp. 365-383
LONG-TERM IN-VITRO CORRECTION OF ALPHA-L-IDURONIDASE DEFICIENCY (HURLER-SYNDROME) IN HUMAN BONE-MARROW
Authors: FAIRBAIRN LJ LASHFORD LS SPOONCER E MCDERMOTT RH LEBENS G ARRAND JE ARRAND JR BELLANTUONO I HOLT R HATTON CE COOPER A BESLEY GTN WRAITH JE ANSON DS HOPWOOD JJ DEXTER TM
Citation: Lj. Fairbairn et al., LONG-TERM IN-VITRO CORRECTION OF ALPHA-L-IDURONIDASE DEFICIENCY (HURLER-SYNDROME) IN HUMAN BONE-MARROW, Proceedings of the National Academy of Sciences of the United Statesof America, 93(5), 1996, pp. 2025-2030
MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE
Authors: MARGISON GP RAFFERTY JA ELDER RH KELLY J WATSON AJ WILLINGTON MA LEE SM HICKSON I FAIRBAIRN LJ DEXTER TM JELINEK J STOCKING C BAUM C OSTERTAG W EGHYAZI S HANSSON J RINGBORG U DONNELLY D MCMURRY TBH MCCORMICK J MCELHINNEY RS
Citation: Gp. Margison et al., MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE, Medicamentos de actualidad, 32, 1996, pp. 51-59
LONG-TERM PROTECTION OF HEMATOPOIESIS AGAINST THE CYTOTOXIC EFFECTS OF MULTIPLE DOSES OF NITROSOUREA BY RETROVIRUS-MEDIATED EXPRESSION OF HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE
Authors: JELINEK J FAIRBAIRN LJ DEXTER TM RAFFERTY JA STOCKING C OSTERTAG W MARGISON GP
Citation: J. Jelinek et al., LONG-TERM PROTECTION OF HEMATOPOIESIS AGAINST THE CYTOTOXIC EFFECTS OF MULTIPLE DOSES OF NITROSOUREA BY RETROVIRUS-MEDIATED EXPRESSION OF HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE, Blood, 87(5), 1996, pp. 1957-1961
O-6-BENZYLGUANINE INCREASES THE SENSITIVITY OF HUMAN PRIMARY BONE-MARROW CELLS TO THE CYTOTOXIC EFFECTS OF TEMOZOLOMIDE
Authors: FAIRBAIRN LJ WATSON AJ RAFFERTY JA ELDER RH MARGISON GP
Citation: Lj. Fairbairn et al., O-6-BENZYLGUANINE INCREASES THE SENSITIVITY OF HUMAN PRIMARY BONE-MARROW CELLS TO THE CYTOTOXIC EFFECTS OF TEMOZOLOMIDE, Experimental hematology, 23(2), 1995, pp. 112-116
ERYTHROID DEVELOPMENT OF THE FDCP-MIX A4 MULTIPOTENT CELL-LINE IS GOVERNED BY THE RELATIVE CONCENTRATIONS OF ERYTHROPOIETIN AND INTERLEUKIN-3
Authors: HEYWORTH CM ALAULDIN M CROSS MA FAIRBAIRN LJ DEXTER TM WHETTON AD
Citation: Cm. Heyworth et al., ERYTHROID DEVELOPMENT OF THE FDCP-MIX A4 MULTIPOTENT CELL-LINE IS GOVERNED BY THE RELATIVE CONCENTRATIONS OF ERYTHROPOIETIN AND INTERLEUKIN-3, British Journal of Haematology, 91(1), 1995, pp. 15-22
BCL-2 DELAY OF ALKYLATING AGENT-INDUCED APOPTOTIC DEATH IN A MURINE HEMATOPOIETIC STEM-CELL LINE
Authors: FAIRBAIRN LJ COWLING GJ DEXTER TM RAFFERTY JA MARGISON GP REIPERT B
Citation: Lj. Fairbairn et al., BCL-2 DELAY OF ALKYLATING AGENT-INDUCED APOPTOTIC DEATH IN A MURINE HEMATOPOIETIC STEM-CELL LINE, Molecular carcinogenesis, 11(1), 1994, pp. 49-55
PATERSON SYMPOSIUM 1993 - GENE-THERAPY
Authors: FAIRBAIRN LJ CROSS MA ARRAND JR
Citation: Lj. Fairbairn et al., PATERSON SYMPOSIUM 1993 - GENE-THERAPY, British Journal of Cancer, 69(5), 1994, pp. 972-975
THE MOLECULAR CONTROL OF HEMATOPOIESIS
Authors: DEXTER TM FAIRBAIRN LJ
Citation: Tm. Dexter et Lj. Fairbairn, THE MOLECULAR CONTROL OF HEMATOPOIESIS, Anti-cancer drugs, 4, 1993, pp. 5-12
SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS
Authors: FAIRBAIRN LJ COWLING GJ REIPERT BM DEXTER TM
Citation: Lj. Fairbairn et al., SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS, Cell, 74(5), 1993, pp. 823-832
Risultati: 1-21 |